Research basics • May 20, 2026
Peptide Evidence Levels Explained
A practical framework for ranking peptide claims from marketing copy to preclinical evidence, human trials, and regulatory documents.
Save the COA and claim-checking prompts.
Get education-first checklists before you evaluate supplier pages, study abstracts, or social-media claims.
Lowest signal: unsourced claims
Social posts, supplier descriptions, and forum summaries are not evidence by themselves. They may be useful leads, but they need primary-source checks.
If a claim has no author, date, method, endpoint, or citation, treat it as unverified marketing language.
Middle signal: mechanisms and preclinical data
Mechanism papers, cell work, and animal models can explain why researchers are interested in a peptide. They do not prove broad human outcomes.
Use them to understand hypotheses, not to make personal-use or treatment decisions.
Stronger signal: well-described human evidence
Human trials, peer-reviewed results, transparent endpoints, and regulatory reviews are stronger signals when the claim matches the data.
Even then, check population, duration, adverse events, and whether the exact peptide and context match the claim being made.
Sources to start with
Keep peptide claims source-first.
Use the starter kit to check evidence level, COAs, and claim boundaries without drifting into protocols or medical advice.